Solstice Secures $21M Series A for Pharma Marketing
Solstice raised $21M in Series A funding to help pharma brands cut MLR review cycles from months to under 48 hours using AI and in-house experts.
Showing 1–1 of 1
Solstice raised $21M in Series A funding to help pharma brands cut MLR review cycles from months to under 48 hours using AI and in-house experts.